Dr. Sergei Petukhov is a Partner of Enso Ventures. Dr. Petukhov was a Managing Director at CLS Capital, he worked at RUSNANO investment fund and was an advisor at Kaye Scholer LLP for number of US pharmaceutical companies. Dr. Petukhov leads Enso Ventures’ biotechnology investments and serves as a board member / board observer at Enso Ventures’ portfolio companies including Cavion, NeuroVia, Seres Therapeutics, Galera Therapeutics and Cellectar Biosciences. Dr. Petukhov worked and studied at The Rockefeller University, The University of Edinburgh, The University of Cambridge and Moscow 1st Medical Academy.
Sergei is attending / has attended:
The 2018 New York Venture Summit
The 2017 New York Venture Summit